Carotenoids, found in the fruit and different organs of bitter melon (Momordica charantia), have attracted great attention for their potential health benefits in treating several major chronic diseases. Therefore, study related to the identification and quantification of the medically important carotenoid metabolites is highly important for the treatment of various disorderes. The present study involved in the identification and quantification of the various carotenoids present in the different organs of M. charantia and the identification of the genes responsible for the accumulation of the carotenoids with respect to the transcriptome levels were investigated. In this study, using the transcriptome database of bitter melon, a partial-length cDNA clone encoding geranylgeranyl pyrophosphate synthase (McGGPPS2) 
Introduction
Momordica charantia (family Cucurbitaceae), commonly known as bitter gourd or bitter melon, is a popular herb found in Asia, Africa, and the Caribbean. As a medicinal plant, bitter melon is used in the treatment of several diseases or conditions including diabetes, HIV, viral infections, cancer, inflammation, ulcers, and sepsis (Chao et al., 2014; Liaw et al., 2015) . Researchers have found that, with respect to its pharmaceutical applications, the important components of bitter melon are the phenolic, flavonoid, triterpene, and carotenoid compounds, including alpha and beta-carotene, lycopene, and zeaxanthin (Liaw et al., 2015) .
The Carotenoids derivative present in the vegetables and fruits were known for their medical applications especially in controlling the chronic and vascular diseases (Khoo et al., 2011) . Till today more than 600 types of Carotenoids are identified from various plant specieses (Khoo et al., 2011) . The color of carotenoids also attracts both pollinators and seed dispersal agents to flowers and fruit and also the starting molecules for the synthesis of abscisic acid which is mainly involved in the plant stress regulations. Vita-2011a,b) . In human vitamin A deficiency causes various visionary diseases such as xerophthalmia, and blindness. Also, consumption of carotenoids help in reducing the risks of cancer, cataract formation and heart related disease in human. In carotenoid biosynthetic pathway, dimethylallyl pyrophosphate (DMAPP) catalysis by geranylgeranyl pyrophosphate synthetase (GGPPS) (Fig. 1) (Tuan et al., 2011a,b) . The genes responsible for the metabolic pathways enzymes were already amplified and characterized in Arabidopsis (Ruiz-Sola and Rodriguez-Concepcion, 2012), Brassica rapa (Li et al., 2015) , tomato (Namitha et al., 2011) , carrot (Clotault et al., 2008) , Momordica cochinchinensis (Hyun et al., 2012) , rice (Beyer et al., 2002) , maize (Messias et al., 2014) , and Scutellaria baicalensis Georgi (Tuan et al., 2015) .
In recent years, several genes in the M. charantia carotenoid biosynthesis pathway have been cloned and characterized including phytoene synthase (McPSY), phytoene desaturase (McPDS), carotenoid cleavage dioxygenase 1 (McCCD1), carotenoid cleavage dioxygenase 4 (McCCD4), 9-cis-epoxycarotenoid dioxygenase (McNCED) . To date, no comparative studies have been performed examining the genes from M. charantia. Here, we have examined the levels of McGGPPS, McZDS, McLCYE, McLCYB, McCHXB, and McZEP in different organs, as well fruit at different stages of maturation, from M. charantia. This is the first description of these enzymes in M. charantia, and it marks a first step toward possible bioengineering of M. charantia crops to increase the yield of these medically important carotenoids.
Materials and methods

Plant material
Seeds of a Chinese cultivar of bitter melon (Momordica charantia L.) were purchased from Beijing Namo Tech.-Trade Co. Ltd (Beijing, China). After three months, different bitter melon organs including roots, stems, old leaves, young leaves, male flowers, female flowers, and fruit at four different stages of maturation (Table S1) were collected and harvested.
RNA isolation and cDNA synthesis
RNeasy Plant mini kit (QIAGEN, Valencia, CA, USA) was used for the extraction and purification of the total RNA from different organs of M. charantia . After extraction, 1 lg of high-quality total RNA was used for the preparation of cDNA synthesis. The cDNA was synthesized using the ReverTra Ace-a-kit (Toyobo Co. Ltd., Osaka, Japan).
Sequence analysis
Using sequence data from the sequencing of complementary DNA (cDNA) libraries obtained from M. charantia seedlings (data not shown). The genes that showed maximum identity and similarity were selected for further study (Tuan et al., 2011a,b (Tuan et al., 2011a,b) .
Extraction and high performance liquid chromatography (HPLC) analysis of carotenoids from M. charantia
The extraction method used for carotenoid analysis in bitter melon was similar to that described by Tuan et al. (2011a,b) . Gradient elution system was used for the complete separation of the individual carotenoid components. For the mobile solvent preparation 10 mM ammonium acetate was dissolved in (92% of methanol and 8% of water (Solvent A) and 100% methyl tert-butyl ether (MTBE) (Solvent B). Initially the column was eluted with 83% A and 17% B for 23 min, after that 70% A and 30% B for 29 min, 59% A and 41% B for 35 min, 30% A and 70% B for 40 min, 30% A and 
Gene expression of carotenoid biosynthesis genes in different M. charantia organs
The expression levels of the studied genes in roots, stems, young leaves, old leaves, male flowers, female flowers, and four fruit stages from M. charantia using real-time PCR was presented in Figs. 2 and 3. Among the carotenoid biosynthetic genes of M. charantia, considerable levels of almost all the genes were detected in leaves, whereas only McCHXB was expressed at high levels in the roots. Considerable levels of McGGPPS1 and McGGPPS2 were detected in leaves (Fig. 2) , whereas only small levels were found in other organs. However, expression levels of these two GGPPSs in leaves varied depending on the age of the leaf; McGGPPS1 had high expression levels in young leaves, whereas McGGPPS2 had high expression levels in old leaves. (Fig. 3) . Specifically, expression barely changed from stage 1 to stage 3.In contrast, McLCYE2 decreased from stage 1 to stage 4, whereas expression of McLCYB increased from stage 1 to stage 3, but then decreased at stage 4.
HPLC analyses of carotenoid in different M. charantia organs
Carotenoids in the roots, stems, young leaves, old leaves, male flowers, female flowers, and the four stages of fruit maturation, were determined by HPLC analysis of tissue extracts (Tables 3  and 4 ). Carotenoid accumulation was lowest in the roots, the only abundant carotenoid in roots being lutein (4.81 lg/gdry weight (DW)); however, this accumulation was significantly lower than that observed in other organs of bitter melon. These high levels of lutein may explain why low levels of its precursor, a-carotene, were found in M. charantia. a-carotene accumulation was highest in old leaves (41.06 lg/g DW), whereas only small amounts were found in young leaves, stems, male flowers, and female flowers (18.77 lg/g DW, 7.29 lg/g DW, 5.75 lg/g DW, and 5.34 lg/g DW, respectively); there were no detectable levels in roots. bcarotene, including E-b-carotene, 9z-b-carotene, and 13z-bcarotene, synthesized high amounts in M. charantia. Especially the the content of E-b-carotene was higher in old leaves and young leaves (287.03 lg/g DW and 220.12 lg/g DW, respectively), comparable contents were documented the stems, male flowers, and female flowers (51.11 lg/g DW, 65.13 lg/g DW and 56.64 lg/g DW, respectively), and not detected in roots. The accumulation of the isomers 9z-b-carotene and 13z-b-carotenewassimilar, being abundant in old leaves (49.16 lg/g DW and 45.62 lg/g DW, respectively), and young leaves (41.54 lg/g DW and 33.22 lg/g DW, respectively), with low accumulation in male flowers (13.9 lg/g DW and 16 lg/g DW, respectively), female flowers (9.38 lg/g DW and 8.26 lg/g DW, respectively), and stems (8.10 lg/g DW and 8.6 lg/g DW, respectively), and undetectable in roots. M. charantia also contained a small amount of violaxanthin and antheraxanthin in the male flowers (48.91 lg/g DW and 32.29 lg/g DW, respectively) whereas only trace amounts of these carotenoids were found in other organs.
In the fruit of M. charantia, the noted amount of the carotenoids was varied between covering stage 1 to stage 3 to orange (stage 4) ( Table 4 ). For example, zeaxanthin was highest in stage 4 fruit (45.91 g/gDW), followed by stage 3 fruit (9.82 lg/gDW), but undetectable in stage 1 and stage 2 fruit. Lycopene, b-cryptoxanthin, and antheraxanthin only accumulated at the final stage of fruit maturation (stage 4) (being 12.4 lg/gDW, 69.05 lg/gDW, and 7.07 g/gDW, respectively).The accumulation of lutein decreased from stage 1 (41.16 g/gDW) to stage 3 (17.43 lg/gDW), and then increased again at stage 4 (21.89 lg/gDW). The a-carotene content decreased from stage 1 (12.67 lg/gDW) to stage 4 (2.48 lg/gDW).
The b-carotene content, including 13Z-b-carotene, e-b-carotene, 9Z-b-carotene, varied during fruit maturation from stage 1 to stage 4. 13Z-b-carotene and 9Z-b-carotene contents decreased from stage 1 (4.44 lg/gDW, and 3.84 lg/gDW, respectively) to stage 2 (1.79 lg/gDW, and 2.03 g/gDW, respectively), and then further increased at stage 3 (1.93 lg/gDW, and 2.23 g/gDW, respectively) and stage 4 (5.89 lg/gDW, and 2.83 lg/gDW, respectively). In 
Discussion
In our study, two genes encoding geranylgeranyl pyrophosphate synthase (McGGPPS1 and McGGPPS2) were identified. However, the expression level of McGGPPS2 was higher than McGGPPS1 in all different M. charantia organs. Moreover, the gene expression level of McGGPPS2 correlated with the accumulation of total carotenoids being highest in old leaves, followed by young leaves, male flowers, female flowers, stems, and lowest in roots. This result suggests that McGGPPS2 is involved in the production of carotenoids in M. charantia. This result was similar to what has previously been described in a range of other plants. For example, a statistical analysis of the correlation between carotenoid content and candidate gene transcript levels in a maize germ plasam collection revealed that the expression of only one of the three plastidial GGPPS enzymes (GGPPS1) positively correlated with endosperm carotenoid content (Vallabhaneni and Wurtzel, 2009) . Similarly, the Arabidopsis genome contains a family of 12 genes encoding putative GGPPS isoforms (Lange and Ghassemian, 2003) ; however, only one Arabidopsis gene, encoding GGPPS1, has been suggested to be involved in the production of carotenoids (Meier et al., 2011) .
The first committed step in plant carotenoid biosynthesis is the synthesis of phytoene from GGPP; this reaction is catalyzed by phytoene synthase (PSY). The number of PSY genes differs in different plants; Arabidopsis (Ruiz-Sola and Rodriguez-Concepcion, 2012), and Tartary buckwheat contain one PSY gene, tobacco (Busch et al., 2002) and tomato (Giorio et al., 2008) contain two PSY genes, and maize (Li et al., 2008) , rice (Welsch et al., 2008) , and cassava (Arango et al., 2010) contain three PSY genes. Some PSY isoforms are involved in the biosynthesis of carotenoids in other tissues. For example, tomato PSY1 participates in the production of carotenoids in fruit, the seed endosperm (maize PSY1), or the root (maize and rice PSY3). In our study, a single M. charantia PSY gene (McPSY) was expressed in virtually all tissues, and positively correlated with McGGPPS1 expression levels showing high expression levels in young leaves and stage 4 fruit compared to other organs (Figs. 2 and 3) .
The a-carotene content was highest in old leaves, followed by young leaves and lowest in roots, and this correlated well with McLCYE1 expression across the different M. charantia organs. Similarly the expression level of McLCYB correlated well with bcarotene content. Accordingly, we propose that McLCYE1 and McLCYB are involved in the production of carotenoids in M. charantia.
During the maturation of M. charantia fruit, of the contents of zeaxanthin and b-cryptoxanthin, was higher. When the color of the fruit changed from green (stage 1-3) to orange (stage 4), the concomitant increase in zeaxanthin and b-cryptoxanthin content is likely brought about because of increased McCHXB expression. However, in other organs, such as the roots, which have high McCHXB expression, the levels of b-cryptoxanthin and zeaxanthin content did not correspond with McCHXB expression. Based on this, we proposed that McCHXB causes accumulation of b-cryptoxanthin and zeaxanthin in fruit. We also suggested that there is another isoform of CHXB in M. charantia, which has direct influence on the synthesis of b-cryptoxanthin and zeaxanthin in the different organs. It is also evidenced that the two isoforms of the CHXB gene was specific for chromoplasts in flowers and/or the fruit (Galpaz et al., 2006) . In our study, carotenoids were generally found to be at high levels in organs that are exposed to direct light (e.g. leaves, flowers, and stems). This finding is similar to previous studies conducted in M. charantia (Tuan et al., 2011a,b) , Allium sativum (Tuan et al., 2012) , and Chinese cabbage (Fraser et al., 2000) which also found that the levels of carotenoids were very high in the leaves, but very low in the organs not exposed to light (e.g. roots). Collectively, the obtained results were evidenced and were marked as a first step toward possible bioengineering of medically important M. charantia crops to increase the yield of these medically important carotenoids. In the future, the production rate of carotenoids might be increased by the bioengineering tools. 
Conclusion
